In the fourth year of the pandemic, Covid-19 is once again spreading across America and being driven by the recent holidays, fewer precautions and the continuing evolution of Omicron subvariants of the virus.
\nNew sub-variants are causing concern for their increased transmissibility and ability to\u00a0evade some antibodies, but the same tools continue to curtail the spread of Covid, especially bivalent boosters, masks, ventilation, antivirals and other precautions, experts said.
\nYet booster uptake has been \u201cpitiful\u201d, said Neil Sehgal, an assistant professor of health policy and management at the University of Maryland School of Public Health. Antiviral uptake has been\u00a0low, and few mandates on masking, vaccination and testing have resumed in the face of the winter surge, which is once again putting pressure on health systems.
\nNew Covid hospital admissions are now at the fourth-highest rate of the pandemic,\u00a0according\u00a0to the US Centers for Disease Control and Prevention (CDC). Covid hospitalizations declined somewhat after the summer wave, but never dropped to the low levels seen after previous spikes, persisting through the fall and rising again with the winter holidays.
\n\u201cHospitals are at maximum capacity,\u201d said Brendan Williams, president and CEO of the New Hampshire Health Care Association, of his region\u2019s current rates. \u201cI\u2019m not sure what the trajectory of this thing\u2019s going to be, but I am worried.\u201d
\nThe majority of Covid hospitalizations are among those 65 and older, although the share for children under four\u00a0roughly doubled\u00a0in 2022.
\nIn the past week, Covid deaths\u00a0rose\u00a0by 44%, from 2,705 in the week ending 4 January to 3,907 in the week ending 11 January.
\nThis is one of the greatest surges of Covid cases in the entire pandemic, according to\u00a0wastewater analyses\u00a0of the virus. It\u2019s much lower than the peak in January 2022, but similar to the summer 2022 surge, which was the second biggest.
\nAnd it\u2019s not done yet. \u201cCertainly it does not appear that we are peaking yet,\u201d Sehgal said.
\nThe Omicron subvariants BQ.1.1 and BQ.1 as well as the quickly expanding XBB.1.5 make up the majority of cases, according to CDC\u00a0estimates. The north-east, where more than 80% of cases are estimated to be from the XBB.1.5 subvariant, has the highest proportion of cases, according to wastewater data.
\n\u201cWith XBB, there\u2019s such a significant transmission advantage that exposure is really risky \u2013 it\u2019s riskier now than it\u2019s ever been\u201d in terms of transmissibility, Sehgal said.
\nOfficial case counts have been\u00a0slower to rise, because of the prevalence of at-home tests and because of a general reluctance to test at all, experts say. Of the tests that are reported, however, positivity rates have been very high, with about one in six tests (16%) turning positive.
\nDespite the high rates of Covid spread, hospitalizations have not yet reached previous peaks seen earlier in the pandemic, probably due to immunity from vaccinations and prior cases, said Stuart Ray, a professor of medicine and infectious diseases at the Johns Hopkins University School of Medicine.
\nBut that protection should not be taken for granted, he said, particularly because immunity wanes.<\/p>\n